Summary
This prediction ended on 10.03.25 with a price of €23.20. The price of Bayer AG has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.89%. Midas has a follow-up prediction for Bayer AG where he still thinks Bayer AG is a Buy. Dividends of €0.12 are taken into consideration when calculating the performance. Midas has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bayer AG | -2.164% | -2.164% | 58.157% |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % |
Comments by Midas for this prediction
In the thread Trading Bayer AG
Die von Midas gewählte maximale Laufzeit wurde überschritten